Evidence map›Paper›PMID 28469090›Full record

ArticleJCI insight2017

Metabolite profiling identifies anandamide as a biomarker of nonalcoholic steatohepatitis.

W Taylor Kimberly, John F O'Sullivan, Anjali K Nath, Michelle Keyes, Xu Shi, Martin G Larson, Qiong Yang, Michelle T Long, Ramachandran Vasan, Randall T Peterson and 3 more

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 75 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Plasma Metabolite Profiles in Response to Chronic Exercise.Medicine and science in sports and exercise · 2018
    Trial
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Observational
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

W Taylor KimberlyCenter for Genomic Medicine, Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA.
John F O'SullivanDivision of Cardiovascular Medicine, Beth Israel Deaconess Hospital, Boston, Massachusetts, USA.
Anjali K NathDivision of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
Michelle KeyesFramingham Heart Study of the National Heart, Lung, and Blood Institute and Boston University School of Medicine, Framingham, Massachusetts, USA.
Xu ShiDivision of Cardiovascular Medicine, Beth Israel Deaconess Hospital, Boston, Massachusetts, USA.
Martin G LarsonFramingham Heart Study of the National Heart, Lung, and Blood Institute and Boston University School of Medicine, Framingham, Massachusetts, USA.
Qiong YangFramingham Heart Study of the National Heart, Lung, and Blood Institute and Boston University School of Medicine, Framingham, Massachusetts, USA.
Michelle T LongFramingham Heart Study of the National Heart, Lung, and Blood Institute and Boston University School of Medicine, Framingham, Massachusetts, USA.
Ramachandran VasanFramingham Heart Study of the National Heart, Lung, and Blood Institute and Boston University School of Medicine, Framingham, Massachusetts, USA.
Randall T PetersonDivision of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
Thomas J WangDivision of Cardiovascular Medicine, Department of Medicine, Vanderbilt University, Nashville, Tennessee, USA.
Kathleen E CoreyDivision of Gastroenterology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
Robert E GersztenDivision of Cardiovascular Medicine, Beth Israel Deaconess Hospital, Boston, Massachusetts, USA.
Massachusetts General Hospital · USBeth Israel Deaconess Hospital · USBoston University · USNational Heart Lung and Blood Institute · USVanderbilt University · US

Funding

PRIMARY PREVENTION TRIAL--DATA COORDINATING CENTERU01DK048489 · NIDDK · GEORGE WASHINGTON UNIVERSITY · PI JABLONSKI, KATHLEEN ANN, TEMPROSA, MARINELLA · 1994 to 2021
$84.8M
Metabolomic predictors of insulin resistance and diabetesR01DK081572 · NIDDK · VANDERBILT UNIVERSITY · PI CLISH, CLARY B, GERSZTEN, ROBERT E · 2008 to 2025
$9.3M
Metabolomic Biomarkers of Early Myocardial InjuryR01HL098280 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI GERSZTEN, ROBERT E, SABATINE, MARC S · 2010 to 2014
$3.7M
Metabolomic predictors of stroke in REGARDSR01NS099209 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI KIMBERLY, WILLIAM TAYLOR · 2017 to 2021
$2.4M
Metabolomic analysis of acute stress hyperglycemia in ischemic strokeK23NS076597 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI KIMBERLY, WILLIAM TAYLOR · 2011 to 2015
$959k
The Impact of Obstructive Sleep Apnea on Non-Alcoholic Fatty Liver DiseaseK23DK099422 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI COREY, KATHLEEN ELIZABETH · 2013 to 2017
$938k
NHLBI NIH HHS R01 HL098280NIDDK NIH HHS K23 DK099422NIDDK NIH HHS R01 DK081572NIDDK NIH HHS U01 DK048489NINDS NIH HHS K23 NS076597NINDS NIH HHS R01 NS099209
6 · The paper itself

Abstract

The discovery of metabolite-phenotype associations may highlight candidate biomarkers and metabolic pathways altered in disease states. We sought to identify novel metabolites associated with obesity and one of its major complications, nonalcoholic fatty liver disease (NAFLD), using a liquid chromatography-tandem mass spectrometry method. In 997 individuals in Framingham Heart Study Generation 3 (FHS Gen 3), we identified an association between anandamide (AEA) and BMI. Further examination revealed that AEA was associated with radiographic hepatic steatosis. In a histologically defined NAFLD cohort, AEA was associated with NAFLD severity, the presence of nonalcoholic steatohepatitis, and fibrosis. These data highlight AEA as a marker linking cardiometabolic disease and NAFLD severity.

Indexed as

GastroenterologyMetabolism

Identifiers

PMID28469090
PMCPMC5414569
OpenAlexW2611147501

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.